Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1naresh

Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Table 6: Comparison of diagnostic performance on combined pre- and postcontrast images in patients administered gadobenate dimeglumine at doses of ≤0.08 mmol/kg body weight compared with doses >0.08 mmol/kg body weight
End Point Reader ≤0.08 mmol/kg (n = 52) >0.08 mmol/kg (n = 37) P Value^{^a}
Tumor vs nontumor 1 50 (96.2%) 34 (91.9%) .645
2 45 (86.5%) 36 (97.3%) .133
3 47 (90.4%) 35 (94.6%) .695
Specific diagnosis 1 40 (76.9%) 25 (67.6%) .344
2 38 (73.1%) 25 (67.6%) .64
3 35 (67.3%) 24 (64.9%) .824
↵a Fisher exact test.

End Point	Reader	≤0.08 mmol/kg (n = 52)	>0.08 mmol/kg (n = 37)	P Value^{^a}
Tumor vs nontumor	1	50 (96.2%)	34 (91.9%)	.645
	2	45 (86.5%)	36 (97.3%)	.133
	3	47 (90.4%)	35 (94.6%)	.695
Specific diagnosis	1	40 (76.9%)	25 (67.6%)	.344
	2	38 (73.1%)	25 (67.6%)	.64
	3	35 (67.3%)	24 (64.9%)	.824